Methyl 4-acetamido-2-hydroxybenzoate, identified by the CAS number 4093-28-1, is a notable organic compound with significant utility in the chemical and pharmaceutical industries. Its primary claim to fame is its role as a key intermediate in the synthesis of Mosapride, a prokinetic agent that enhances gastrointestinal motility. Understanding its chemical characteristics and production methods is crucial for anyone involved in drug development or specialized chemical synthesis.

The synthesis of Methyl 4-acetamido-2-hydroxybenzoate is a well-defined process, typically involving the acetylation of methyl 4-aminosalicylic acid. This chemical transformation, carried out under controlled conditions using reagents such as acetyl chloride and sodium bicarbonate, yields the target molecule with high purity. Manufacturers in China have optimized this process, ensuring consistent quality and large-scale production capabilities to meet global demand. This makes them a preferred source for businesses looking to buy methyl 4-acetamido-2-hydroxybenzoate, ensuring a stable supply for ongoing research and manufacturing.

Beyond its primary role in Mosapride synthesis, Methyl 4-acetamido-2-hydroxybenzoate serves as a valuable building block in broader organic chemistry. Its molecular structure, featuring an acetamido group, a hydroxyl group, and a methyl ester, offers multiple sites for further chemical modification. This versatility makes it an attractive compound for custom synthesis projects, enabling the creation of complex molecules for various research purposes, including the development of new pharmaceuticals, agrochemicals, and materials science applications. The ease of online procurement from reliable China suppliers further facilitates its accessibility for these diverse applications.

The consistent quality and competitive pricing offered by Chinese manufacturers of Methyl 4-acetamido-2-hydroxybenzoate underscore their importance in the global chemical supply chain. By leveraging their expertise in chemical synthesis and production, industries can efficiently obtain this essential intermediate, thereby advancing their research and development goals and ensuring the continued availability of important medications.